Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Blood Advances|November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHLSolomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.
Blood Advances|January 4, 2018
High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesisKatharine A Lombardo, David G Coffey, Alicia J Morales, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over timeShashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu, et al.
The Lancet. Oncology|July 6, 2023
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trialAndrew J Cowan, Margot J Pont, Blythe D Sather, et al.
Bone Marrow Transplantation|July 26, 2020
90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myelomaSherilyn A Tuazon, Brenda M Sandmaier, Theodore A Gooley, et al.
Nature Communications|September 2, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myelomaDavid G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova, et al.
Blood|April 8, 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-upSherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, et al.
Transplantation and Cellular Therapy|September 10, 2025
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 TrialsAndrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell LymphomaAustin D Newsam, Bachisio Ziccheddu, Venu Venkatarame Gowda Saralamma, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detectionAntonio De Falco, Piera Grisolia, Raffaella Giuffrida, et al.
Pageof 4